1-5 of 5
Malcolm Smith, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Single Mouse Trial Platform for Evaluation of Novel Agents in Acute Lymphoblastic Leukemia By the Pediatric Preclinical Testing Consortium

Richard B. Lock, PhD, Kathryn Evans, Tara Pritchard, Cara Toscan, Chelsea Mayoh, Beverly Teicher, Raushan T Kurmasheva, Peter J Houghton, Malcolm Smith, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4010.
https://doi.org/10.1182/blood-2018-99-113207
Published: 2018
Journal Articles

Mutations in the RAS Signaling, B-Cell Development, TP53/RB1, and JAK Signaling Pathways Are Common in High Risk B-Precursor Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project.

Jinghui Zhang, Ph.D., Charles G. Mullighan, MBBS(Hons), MSc, MD, Richard C. Harvey, PhD, Kenneth E Buetow, Ph.D, William L. Carroll, MD, I-Ming Chen, MS, Meenakshi Devidas, PhD, Michael Edmonson, Daniela Gerhard, PhD, Ying Hu, PhD, Mignon L. Loh, MD, Letha A Phillips, BS, Gregory H Reaman, M.D., Mary V. Relling, PharmD, Malcolm Smith, MD, PhD, James R. Downing, MD, Cheryl L. Willman, MD, Stephen P Hunger, MD
Journal: Blood
Blood (2009) 114 (22): 85.
https://doi.org/10.1182/blood.V114.22.85.85
Published: 2009
Journal Articles

Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia

Charles G. Mullighan, MBBS(Hons), MSc, MD, Xiaoping Su, PhD, Jinghui Zhang, PhD, Ina Radtke, PhD, Letha A Phillips, BS, Christopher B Miller, BS, Jing Ma, PhD, Wei Liu, PhD, Cheng Cheng, PhD, Richard C. Harvey, PhD, I-Ming Chen, DVM, MS, Robert Clifford, PhD, William L. Carroll, MD, Gregory Reaman, MD, Meenakshi Devidas, PhD, Daniela S. Gerhard, Ph.D., Wenjian Yang, PhD, W. Paul Bowman, Sheila A. Shurtleff, PhD, Mary V. Relling, PharmD, Malcolm Smith, MD, PhD, Stephen P. Hunger, MD, Cheryl L. Willman, MD, James R. Downing, MD
Journal: Blood
Blood (2008) 112 (11): 427.
https://doi.org/10.1182/blood.V112.11.427.427
Published: 2008
Journal Articles

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Cheryl L. Willman, MD, Huining Kang, PhD, Richard C. Harvey, PhD, I-Ming Chen, DVM, MS, Charles Mullighan, MD, James R. Downing, MD, Mary V. Relling, PharmD, Jinghui Zhang, PhD, Daniela Gerhard, PhD, Malcolm Smith, MD, PhD, Kevin K. Dobbin, PhD, Gregory Reaman, MD, Stephen Hunger, MD
Journal: Blood
Blood (2008) 112 (11): sci-8.
https://doi.org/10.1182/blood.V112.11.sci-8.sci-8
Published: 2008
Journal Articles

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Richard C. Harvey, PhD, I-Ming Chen, MS, Kerem Ar, MS, Stephen P. Hunger, MD, Mignon Loh, MD, Eric C. Larsen, MD, Meenakshi Devidas, PhD, Elizabeth Raetz, MD, Gregory Reaman, MD, William L. Carroll, MD, Naomi Winick, MD, Malcolm Smith, MD, PhD, Kevin K Dobbin, PhD, Cheryl L. Willman, MD
Journal: Blood
Blood (2008) 112 (11): 2256.
https://doi.org/10.1182/blood.V112.11.2256.2256
Published: 2008